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Abstract
Ethnic groups can display differential genetic susceptibility to infectious diseases. The arthro-
pod-born viral dengue disease is one such disease, with empirical and limited genetic evidence
showing that African ancestry may be protective against the haemorrhagic phenotype. Global
ancestry analysis based on high-throughput genotyping in admixed populations can be used to
test this hypothesis, while admixture mapping can map candidate protective genes. A Cuban
dengue fever cohort was genotyped using a 2.5 million SNP chip. Global ancestry was ascer-
tained through ADMIXTURE and used in a fine-matched corrected association study, while local
ancestry was inferred by the RFMix algorithm. The expression of candidate genes was evalu-
ated by RT-PCR in a Cuban dengue patient cohort and gene set enrichment analysis was per-
formed in a Thai dengue transcriptome. OSBPL10 and RXRA candidate genes were identified,
with most significant SNPs placed in inferred weak enhancers, promoters and lncRNAs. OSB-
PL10 had significantly lower expression in Africans than Europeans, while for RXRA several
SNPs may differentially regulate its transcription between Africans and Europeans. Their expres-
sion was confirmed to change through dengue disease progression in Cuban patients and to
vary with disease severity in a Thai transcriptome dataset. These genes interact in the LXR/
RXR activation pathway that integrates lipid metabolism and immune functions, being a key
player in dengue virus entrance into cells, its replication therein and in cytokine production.
Knockdown of OSBPL10 expression in THP-1 cells by two shRNAs followed by DENV2 infec-
tion tests led to a significant reduction in DENV replication, being a direct functional proof that the
lower OSBPL10 expression profile in Africans protects this ancestry against dengue disease.
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Author summary
Dengue is a concern of worldwide health authorities given the increase on virus and vec-
tor dispersions. So far only one traditional GWAS survey has been performed in Vietnam-
ese children. This disease is also epidemic in tropical and subtropical regions of the
Americas, where most populations descend from a dynamic admixture between African,
European and Native American backgrounds. Empirical evidence claimed that African
descent was protective against dengue haemorrhagic phenotype in the Cuban population,
and this study is the first to apply admixture mapping to identify candidate genes that
confer African protection. We also present evidence that two candidate genes, OSBPL10
and RXRA, are differentially expressed along dengue disease progression in Cuban
patients and in a Thai dengue transcriptome dataset, and directly show that knockdown
of OSBPL10 gene expression leads to a significant reduction in DENV2 replication. A very
important overall result of our work is that it provides a unifying framework for many
genes that have been said to be protective in dengue. Our evidence places the LXR/RXR
activation pathway at the center of natural dengue protection, and supports pursuing ther-
apeutic techniques involving synthetic ligands of nuclear receptor genes or kinases inhibi-
tors that interact with proteins involved in lipid metabolism.
Introduction
Dengue is an emerging arthropod-born viral disease caused by the infection with any of the
four dengue viruses (DENV-1 to 4). The virus is transmitted to humans by Aedes aegypti and
Aedes albopictus mosquitoes. Morbidity and mortality associated with severe dengue infection
render this disease a major increasing public health problem throughout tropical and subtropi-
cal regions. Dengue illness is also attracting awareness in Europe and in the United States as
climate change and globalisation enlarge the geographic dispersion of the vector and the
viruses [1]. A dengue infection can evolve from a subclinical infection, a relatively mild, self-
limited infection known as dengue fever (DF), to the severe disease called dengue haemorrha-
gic fever (DHF), which may evolve to a life-threatening hypovolemic shock (dengue shock
syndrome, DSS [2]). But only a small proportion of antibody-positive individuals develops
DHF/DSS, while the vast majority suffers an asymptomatic infection or the mild disease. This
differential susceptibility to disease severity indicates that besides immune factors, the host
genetics may influence the infection outcome, acting in a complex interplay with viral and
environmental factors. Diverse single nucleotide polymorphisms (SNPs) in genes such as
HLA-I, HLA-II, TNF-α, IL-10, TGF-β1, FcγRIIa, VDR, CD209 and OAS have been associated
with symptomatic dengue or considered protective against the disease, in Asian and Latin
American populations [3]. Also, MICA and MICB genes have been associated with susceptibil-
ity to dengue in Cuba [4], partially overlapping previous results reported in the only genome-
wide association study (GWAS) performed so far in Vietnamese children, and showing signifi-
cant association of MICB and PLCE1 genes with DSS [5].
Evidence supporting the impact of human genetic factors on infection outcome also comes
from differences between ethnic groups in developing severe DHF/DSS symptoms [6]. As
early as in 1906, it was reported that Cuban dark-skinned individuals showed a remarkable
resistance against dengue disease compared with light-skinned individuals [7]. This early
observation was confirmed during the 1981 Cuban DHF/DSS epidemic of DENV-2 when eth-
nicity was recognized for the first time as a possible host risk factor, and confirmed afterwards
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in several other dengue Cuban outbreaks [8]. The low occurrence of dengue disease in Hai-
tians [9] and in African populations [10] adds further support for this ancestry influence. A
genetic characterization of 30 ancestry informative markers conducted in the Colombian pop-
ulation [11] confirmed the protective effect of African ancestry against severe dengue out-
comes (odds ratios, ORs in 0.963–0.971 interval).
Till recently, population structure as occurs in admixed populations was a major confound-
ing factor, requiring strategies for correction of the association p-values [12]. But admixed
populations are a great advantage in cases of differential ancestry-conferred susceptibility/
resistance to a disease through the use of admixture mapping [13]. The rationale of admixture
mapping is that the ancestry blocks will be distributed at random across the genome, reflecting
the admixture proportions of the parental ancestries, except in candidate gene locations where
statistically significantly different proportions for the ancestry with higher disease levels will be
observed in cases versus controls. It has been shown that this test is statistically more powerful
than traditional GWAS [14]: around 250 samples can provide a 60% power to detect a two-
fold risk due to ancestry, compared to the thousands of samples required in GWAS. In fact,
because of the recentness of admixture, the typical ancestry blocks are significantly larger than
haplotype blocks, thus lowering the multiple testing burden. This strategy has been successfully
applied in African-Americans and Latin-Americans, in association with various diseases, such
as asthma [15] and type 2 diabetes [16].
Cuba is advantageous for studies of ancestry-conferred DHF susceptibility/protection. The
current Cuban population is mainly derived from the mix of two well-defined ancestral popu-
lations: European colonizers, who began to arrive in 1492 from the Iberian Peninsula, followed
by other countries; and enslaved Africans, arriving in the 16th century, mainly from West
Africa. The contribution of the first aboriginal Cuban inhabitants, almost totally exterminated
during the Spanish conquest, is almost negligible [17]. The Western and Eastern sides of the
island show differences in historic settlement, with European descendants concentrating in
the capital [17]. DENV experience has also been different among them. After an absence of 40
years, DENV1 was reported in 1977 and transmitted to nearly one-half of the Cuban popula-
tion. Four years later, DENV2 (Asian origin) infected approximately 25% of the population,
and a large DHF/DSS epidemic occurred. In 1997, another Asian DENV2 virus entered the
country, producing a local epidemic in the municipality of Santiago de Cuba. In 2001, DENV3
(Asian genotype), was detected in Havana city [18]. In 2006, the circulation of DENV4 was
reported in Havana, while DENV3 affected Guantanamo [19].
We conducted a GWAS of 2.5 million SNPs in 274 Cubans, including patients (DF and
DHF) of the 2006 dengue epidemic, from Havana (west) and Guantanamo (east) cities, and in
geographically matched asymptomatic individuals and population controls. The high level of
admixture in Cuba enabled us to apply the first admixture mapping, thus facilitating the iden-
tification of candidate markers ethnically associated with dengue infection. Firstly, we con-
ducted a global admixture analysis which allowed us to confirm the statistically significant
decrease of African ancestry in the DHF cohort and to fine tune the association analysis in the
admixed Cubans (cases and controls were paired to not differ more than 2% in African ances-
try), whose statistical burden is 2.6x10-8. Secondly, we performed a local ancestry assignment
along chromosomes which identified the precise regions (and genes) where the African ances-
try was significantly higher in asymptomatic compared with DHF (above 3SD threshold in the
difference in African ancestry between controls-cases). The fine-tuned association analysis can
identify a few SNPs (located in a small chromosomal region) that confer reasonable individual
risk/protection; the local ancestry assignment can identify ancestry-related blocks (medium to
big chromosomal regions, depending on the time since admixture) containing SNPs confer-
ring low-medium risk/protection, which would escape the association test. We also performed
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a functional test consisting in knocking down the expression of one candidate gene by shRNA,
followed by DENV infection assays.
Results
Global ancestry influence in dengue infection outcome
The genome-wide Cuban screening confirmed that all individuals in this study have a mixed
ancestral composition. The main ancestry backgrounds (Fig 1A for K = 4) derive from Africa
(represented by the blue colour) and Europe (red), but the range follows the entire spectrum of
admixture, from nearly 0% African and 90% European to the inverse ratio, while the remaining
10% are from Native American (yellow) and East Asian (orange) influences. Comparing the
population control groups from Havana and Guantanamo (HC and GC) as references for the
two geographical regions, the average proportions of the African component are statistically dif-
ferent (25.2% and 35.3%, respectively; two-tailed Wilcoxon rank-sum test p = 1.43x10-3), identi-
cal to published values [20]. The Native American component was 6.5% in Havana and 13.5%
in Guantanamo, values statistically significantly different (p = 1x10-6); while the East Asian
component was of 1.9% and 0.7% respectively (p = 0.224). A finer description of Cuban ances-
try is presented in Supplementary section 1.2 (Figs A-C in S1 Text). This includes confirmation
that, despite the statistical differences in the African/European components between Havana
and Guantanamo, the sub-structures within those two components in the two cities are identi-
cal, not favouring differential migration events into the two parts of the island (Figs D-E in S1
Text).
Focusing on the global ancestry among the Cuban cohorts (Fig 1B), the average African
ancestry is significantly lower in DHF (22.9%) when compared with DF, controls and especially
asymptomatic groups (30.6%, p-value = 0.025; 30.0%, p-value = 0.041; 34.7%, p-value = 0.013,
respectively). These results confirmed that African ancestry is protective against DHF pheno-
type in Cuba, and the odds ratios are very similar to the ones reported in Colombia [11]
(Table 1). Nevertheless, the evidence of ancestry influence in dengue was not so straightforward
when the samples were divided according to the city of origin: in Havana, the African ancestry
is even more significantly lower in DHF (10.3%) compared with DF, controls and especially
asymptomatic (24.4%, p-value = 0.009; 25.2%, p-value = 0.015; 33.0%, p-value = 0.002, respec-
tively) and OR even more protective (Table 1); while in Guantanamo, the African averages are
statistically identical between all groups (35.3% in controls, 38.1% asymptomatic, 36.4% DHF
and 36.0% DF). This complex relation was confirmed by an iterative model (Fig F in S1 Text).
Our data show that there is an African protection conferred against DHF in Cuba, but other
currently unknown confounding factors render it a complex relation, even in such a geographi-
cal restricted scenario as Cuba.
Fine-matched corrected population structure followed by association
evaluation
The fine-matched corrected association tests (Tables C-E in S1 Text) identified the lowest p-
values (10−6–10−7) in the DHF comparison (HCG–haemorrhagic comparison group) for six
highly linked (Fig 2A; Table I and Figs N-P in S1 Text) SNPs extending for 8,370 bps in chro-
mosome 3, in a region containing the OSBPL10 (oxysterol binding protein-like 10) gene (Fig
2B). These p-values are close to the significant cutoff of 10−8. OSBPL10 protein is involved in
lipid transport and steroid metabolism. Curiously, the most frequent haplotypes in African
and European populations consist totally of the alternative alleles for all six SNPs, and attain
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Fig 1. The global ancestry in Cuba and its influence on susceptibility to dengue. (A) ADMIXTURE results for four ancestral populations (blue
component represents the European ancestry, red the African, yellow the Native American and Orange the East Asian). HC: Havana controls, HA: Havana
individuals with asymptomatic infection, HH: Havana DHF cases, HF: Havana DF cases, GC: Guantanamo controls, GA: Guantanamo individuals with
asymptomatic infection, GH: Guantanamo DHF cases, GF: Guantanamo DF cases. (B) Box plots for the African ancestry in the Cuban groups: controls;
individuals with asymptomatic infection; DF (dengue fever); DHF (dengue haemorrhagic fever). The boxes represent the interquartile range and the whiskers
are the 5% and 95% quartiles. The significant p-values for the two-tailed Wilcoxon rank-sum test between pairs of groups are displayed; non-significant ones
are not displayed.
doi:10.1371/journal.ppat.1006220.g001
Table 1. Odds ratios of the African ancestry influence in DHF phenotype when compared to asymptomatic subjects, in Cuba in general, only
Havana city and in Colombia.
Odds ratio
1% African ancestry 50% African ancestry 100% African ancestry
Cuba 0.979 0.396 0.151
Havana 0.920 0.045 0.012
Colombia* 0.962 0.204 0.042
* From [11].
doi:10.1371/journal.ppat.1006220.t001
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Fig 2. The relevant region on chromosome 3 containing the OSBPL10 gene (A) Manhattan plot for the association analysis in the 54 fine-matched
population structure corrected Cuban pairs of asymptomatic/control versus DHF subjects. (B) The region on chromosome 3, with the haplotype defined by
the six significantly associated SNPs indicated by the red box. Genes on the forward sense are indicated in blue; genes on the reverse sense are indicated
in light brown. (C) Worldwide frequency of the African (blue), European (red) and other (grey) OSBPL10 haplotypes for populations of the 1000 Genomes
project, and also for asymptomatic/control and DHF in Cuba. (D) mRNA expression for homozygous genotypes for African and European OSBPL10
haplotypes in the 1000 Genomes project transcriptome information.
doi:10.1371/journal.ppat.1006220.g002
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frequencies higher than 50% in each continent (Fig 2C). The odds ratio calculated in DHF is
0.25 [95% CI 0.13–0.47] for the African haplotype (Table 2).
By using the 1000 Genomes transcriptome [21], we confirmed that the homozygous indi-
viduals for the OBSPL10 African haplotype have a significantly reduced (by half) expression
(mean value = 0.145) when compared with the homozygous for the European haplotype
(mean value = 0.257; p<0.001; Fig 2D). This indicates that the haplotype affects mRNA expres-
sion. We further ascertained that these non-coding SNPs are not located in the inferred pro-
moter, but they can be related with weaker enhancer regions and are recognised by many
transcription factors, including STAT and RXRA (Fig Q in S1 Text). Besides the haplotype
region, the segment immediately 5’ to it (within the gene) has some SNPs with significant p-
values in the association test that are also regulatory regions in several cell types (Table O and
Fig R in S1 Text). Although there is no current good database to check eQTLs in African popu-
lations, we used GTEx despite its highly European-biased dataset (84.3%). The six identified
OSBPL10 SNPs are not identified in GTEx as eQTLs, but surveying the eQTLs located on that
chromosomal region, there is one with frequency differences between African and European
populations (rs7642435, at position 32036787; 1000 Genomes frequency in Africa–A = 0.092,
G = 0.908; 1000 Genomes frequency in Europe–A = 0.723, G = 0.277), which presents alterna-
tive homozygous genotypes associated with our African/European haplotypes: “African” hap-
lotype with rs7642435_GG and “European” haplotype with rs7642435_AA. As can be
confirmed in Fig S in S1 Text, rs7642435_GG has a significant reduction of OSBPL10 expres-
sion compared with rs7642435_AA, and this SNP is predicted to have an eQTL effect (poste-
rior probability>0.9) in several tissues: artery (aorta, coronary and tibial), brain (nucleus
accumbens and caudate), liver, adrenal gland, pancreas, esophagus (muscularis and gastro-
esophageal junction), stomach, nerve and cells-transformed fibroblasts. The remaining eQTLs
in the region are almost fixed in both African and European populations. Possibly, our haplo-
type association is identifying the rs7642435 eQTL, although more information on African
eQTLs is needed in order to ascertain other possible eQTLs in the OSBPL10 region.
This extended OSBPL10 segment (haplotype and immediate 5’ region) has probably been
under positive selection in the African Yoruban population, as inferred in the Haplotter tool
based on HapMap dataset (iHS measure; Fig T in S1 Text). The positive selection of OSBPL10
gene was confirmed in Cuban HCG when applying XP-EHH measure (Fig M and Tables M-N
in S1 Text). Therefore, it seems that the OSBPL10 haplotype and its 5’ region, although non-
Table 2. Odds ratios of the African OSBPL10 haplotype and RXRA alleles in DHF when compared with asymptomatic/control and tests (identified
by Y) where statistical significant evidence was detected for each gene.
Gene Haplotype SNP Position Haplotype
allele
Odds
ratio
OR 95%
confidence
interval
A B C D E F
OSBPL10 African haplotype rs4600849
rs11129475 rs6419811 rs11718700
rs975406 rs7639637
32027672 32030544 32031135
32033248 32035587 32036042
CTGCCC 0.25 [0.13–0.47] Y Y Y Y Y
RXRA rs12339163 137205188 G 0.36 [0.17–0.77] Y Y Y
rs62576287 137214888 C 0.10 [0.01–0.83]
rs3118593 137426334 A 0.44 [0.25–0.77]
rs4262378 137515156 G 0.41 [0.24–0.72]
rs4424343 137515158 A 0.43 [0.24–0.76]
A—Association; B—Admixture mapping; C—Positive selection (XP-EHH and iHS); D—Expression changes in Cuban patients RT-PCR; E—Expression
changes in Thai transcriptome dataset; F—Expression changes between African and European haplotypes/genotypes in 1000 Genomes transcriptome.
doi:10.1371/journal.ppat.1006220.t002
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coding, bear several expression regulatory SNPs with large frequency differences between Afri-
cans and Europeans, probably due to selection events.
Several other SNPs located on genes (mostly one or two SNPs per gene) reached association
p-values of 10−5. By checking which SNPs are more frequent in Africa (information from the
1000 Genomes database) and which genes would have differential gene expression between
dengue patients and control/convalescent subjects (in the whole blood transcriptome obtained
in a Thai dengue dataset [22] and using a linear discriminant analysis effect size method, LEfSe
[23], for high-dimensional class comparisons), besides OSBPL10, a few kinases or kinase-
related genes are amongst the most significant genes (Fig G in S1 Text): CAMK1D (calcium/
calmodulin-dependent protein kinase ID), MAPKAPK5 (mitogen-activated protein kinase-
activated protein kinase 5), PIK3AP1 (phosphoinositide-3-kinase adaptor protein 1), SNRK
(sucrose nonfermenting related kinase), GNA14 (guanine nucleotide binding protein (G pro-
tein), alpha 14) and DAB-1 (dab, reelin signal transducer, homolog 1 (Drosophila)).
The non-African set (Fig H in S1 Text) has more variable and generalized functions, dealing
with hemostasis (DOCK10), phospholipid binding (PLEKHM1L), protein serine/threonine
kinase activity and ribosomal protein S6 kinase activity (RPS6KA2), protein homodimerization
activity and HMG box domain binding (OLIG2), sequence-specific DNA binding transcrip-
tion factor activity and chromatin binding (TSHZ3).
Fine-matched corrected population structure followed by admixture
mapping
The admixture mapping led to the identification of locally enriched African regions across the
genome in the asymptomatic/controls (Figs I-K and Tables F-H in S1 Text). One of these
regions is located on chromosome 9 (detected at HCG and FCG/fever comparisons), contain-
ing the RXRA (retinoid X receptor alpha), COL5A1 (collagen type V alpha 1) and FCN2 (ficolin
(collagen/fibrinogen domain containing lectin) 2) genes. We confirmed from the expression
data on Thai dengue patients [22] that only RXRA has statistically significant altered expres-
sion (Fig L in S1 Text), supporting several lines of evidence linking retinoid receptors with
infectious diseases and dengue [24]. Detailed description of other significant regions is pre-
sented in supplementary material sections 1.5 and 1.6 (Tables K-L in S1 Text).
We checked the SNPs with significant association p-values in the RXRA-COL5A1 region in
the Cuban HCG (Fig 3; Table J in S1 Text), and verified that two locations have higher signifi-
cant p-values and OR between 0.103–0.436 (Table 2). The most significant p-values are for
three intergenic SNPs (rs4262378, rs4424343 and rs3118593) located in inferred enhancers
(Table P in S1 Text). The other location is immediately before and in the beginning of RXRA,
and contains SNPs rs12339163 and rs62576287 (the latter only exists in Africa with a 9% fre-
quency) placed in poised and weak promoters and weak enhancers. From these various signifi-
cant SNPs, only rs3118593 is within a promoter and a lncRNA (RP11-473E2.4; Fig 3), and
interestingly, according to the GTEx portal, the patterns of expression for RXRA and RP11-
473E24 genes in the various human tissues are totally opposite, with RXRA being mainly
expressed in liver, muscle, skin and whole blood while almost not expressed in brain and testis,
and the other way around for RP11-473E24 (Figs U-W in S1 Text). The opposite expression
pattern between the RXRA and RP11-473E24 genes raises the possibility that the lncRNA
silences the expression of RXRA. When checking the RXRAmRNA expression for the typical
African and European genotypes in those SNPs (based on the 1000 Genomes transcriptome
from lymphoblastoid cell lines), no statistical differences were observed (data not presented).
We further performed association tests for the whole RXRA-COL5A1 region in the 1000
Genomes transcriptome comparing RXRA high- and low-expression groups within Africans
Admixture mapping in Cuban individuals infected by dengue
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and Europeans. The African test shows that there are 37 significant (at the 1% level) SNPs sur-
rounding RXRA gene, including rs3118593, that are differently frequent between the high-
with low-expression groups, and these can be regions for expression regulation of the gene
(Fig 3; Table Q in S1 Text). While in Europe, the number of significantly differentiated SNPs is
much lower, only six (Fig 3; Table R in S1 Text). A reasonable hypothesis would be that the
advantage in Africans is related with a faster control of RXRA expression.
OSBPL10 and RXRA expression in dengue patients and focused
enrichment analysis
The genetic evidence collected in this work, summed up in Table 2, for the involvement of
OSBPL10 and RXRA genes in the protection against DHF, led us to check their expression in
Cuban patients throughout the infection process (Fig 4). The mRNA expression of RXRAwas
significantly higher during convalescence (day 30) compared to day 3 (p = 0.027), and also
higher than at day 7 after fever onset (not significant). There were no significant differences
between days 3 and 7 after fever onset. These results are comparable with the ones for the Thai
dataset, where RXRA expression is significantly decreased in DF and DHF cohorts when
Fig 3. The RXRA-COL5A1 region with the most significant SNPs highlighted. Map obtained with the LocusZoom tool, using recombination rate
information from the Yoruba reference population. The symbols above the rule represent significant SNPs, for the Cuban data (the pink triangles), the
African comparison between individuals having low (n = 6; lower than 10 RPKM) and high (n = 8; higher than 20 RPKM) RXRA expression (green circles),
the same for European individuals (n = 42 and n = 39, respectively; blue squares).
doi:10.1371/journal.ppat.1006220.g003
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Fig 4. Gene expression for RXRA and OSBPL10 in Cuban dengue patients along the course of disease Data is
shown for all Cuban patients, Cuban patients with warning signs, and the Thai transcriptome dataset for whole blood. [22]
doi:10.1371/journal.ppat.1006220.g004
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compared with controls and convalescent, indicating that this gene expression is decreased
along the disease course, and only returns to normal values in convalescence. The differences
between DF and DHF cohorts did not reach statistical significance, what can be explained by
the small sample size.
The mRNA expression of OSBPL10 was significantly increased by day 7 and in convales-
cence, when compared with day 3 (p<0.001 for both). There is a decrease between day 7 and
convalescence, but it is not significant. In Thai, the DHF group has a significantly higher
OSBPL10 expression compared with all other groups. Considering both datasets, it seems that
OSBPL10 expression is very low in the acute phase, increases significantly at the end of the
acute phase, and decreases again in convalescence. For both genes, results in Cuban patients
showing warning signs were similar to the ones observed in the totality of patients. These
results show that both gene expressions are altered along the dengue disease progression.
We further checked which pathways could have both genes acting together (in Ingenuity
database; https://targetexplorer.ingenuity.com/index.htm), and found that they play a central
role in the LXR/RXR activation pathway, related to cholesterol metabolism and cytokine pro-
duction in macrophages (Fig X and Table S in S1 Text). We performed a gene enrichment
pathway analysis in the Thai dengue transcriptome in whole blood as a surrogate of the LXR/
RXR interaction pathway in macrophages. Unfortunately, there are no robust transcriptome
for hepatocytes, in which the same pathway occurs without the cytokine production. Results
for comparisons of DHF and DF versus convalescent and controls (Figs Y-AA in S1 Text)
showed that the lipid metabolism set of genes is always significantly upregulated in patients,
and the main contributing genes are OSBPL10, LDLR and MSR1, the two last mediating the
entrance of LDL (low-density lipoprotein) to the cell. NF-kB expression is always upregulated
in the convalescents (significantly in DHF comparison), or, biologically more meaningful,
downregulated in patients, with main genes been RXRA and NF-kB. The LXR/RXR activation
set of genes is never statistically significant, but the most contributing genes are NR1H3/LXRA,
ABCA1,ARG2 and NCOR1 up-regulated in DF, and ABCG1, LPL and RXRA down-regulated
in DHF. This analysis reinforces the importance in dengue disease of the enlarged pathway for
LXR/RXR activation, including the cholesterol/lipids metabolism and the NF-kB control of
cytokines. We demonstrated that the African protective genes OSBPL10 and RXRA, which
play central roles in this pathway, are always identified as top differentially expressed genes.
Effect of OSBPL10 knockdown on DENV replication
The two shRNA plasmids used to induce OSBPL10 knockdown in the THP-1 cell line were
very efficient, as measured by mRNA expression (Fig 5A). In fact, no significant differences in
the OSBPL10 expression were observed among THP1/non-transfected and THP1/mock
(mean values of 34.62 and 26.58, respectively; two-tailed t-test p = 0.15). While a noteworthy
reduction in OSBPL10 expression levels was observed in THP1sh1/OSBPL10 assay (mean of
11.11; p = 0.00022 and p<0.00001, compared with THP-1/non-transfected and THP1/mock,
respectively), and an almost complete non-expression in THP1sh2/OSBPL10 assay (mean of
0.30; p<0.00001 and p<0.00001, compared with THP-1/non-transfected and THP1/mock,
respectively).
DENV2 infection assays in these OSBPL10-knockdown cell lines provides robust evidence
that down-modulation of OSBPL10 affects in a direct way DENV replication (Fig 5B). Signifi-
cant (p<0.00001) viral load reductions were observed intracellularly in both OSBPL10 knock-
down cell lines (mean values of 2x107 in THP1/non-transfected, 2x106 in THP1/mock, 2x104
in THP1sh1/OSBPL10 and 2x102 in THP1sh2/OSBPL10), as well as extracellularly (mean val-
ues of 2x107, 2x107, 2x103 and 2x102, respectively).
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Discussion
Human populations are structured in three main groups, African, European and Asian. The
independent selective pressures acting upon these groups can lead different genes to be
selected in adaptation to the same pathogen, and those genes can interact in a common crucial
pathway or in different pathways of additive importance to the disease process.
The current study supports the African-ancestry-conferred resistance to DHF, in compari-
son with European background, concurring with the report in Colombia [11]. It is unlikely
that DENV has exerted this selective pressure, since its associated mortality is low and it does
not alter reproduction. But yellow fever virus, another African-originated flavivirus, which has
a remarkable mortality level (being 6.8 times higher in Caucasians), could have generated pro-
tective genetic variants against itself, hepatitis C virus (HCV) and DENV [25]. It has been
demonstrated that besides infection-related genes, metabolic genes are also under intense
selective pressure, and both can interact as in the case of the low-activity alleles of glucose-
6-phosphatase dehydrogenase providing reduced risk to malaria infection [26]. It is known
that Africans have a lower atherogenic lipid profile, characterized by low triglyceride (T), total
cholesterol, and LDL levels, and high high-density lipoproteins (HDL) levels, when compared
to Europeans [27]. Signs of selection were already identified in West Africans for APOL1 and
CD36 genes involved in lipid metabolism and probably driven by pathogen resistance [28].
Our evidence adds two new genes to the differential lipid profile between Africans and Euro-
peans, which play a role in infectious resistance. We detected signs of positive selection on the
OSBPL10 gene, while balancing selection may have generated additional polymorphisms regu-
lating RXRA expression in Africans.
A direct link between dengue infection progression and lipid profile changes has been
made, so that lipids may be used as predictors of clinical outcome [29]: increased T and HDL
Fig 5. Functional assay of OSBPL10 knockdown and its effect on DENV-replication (A) Box plots for the OSBPL10 mRNA expression in the
various THP1 cells (non-transfected and transfected with mock, sh1 and sh2 plasmids). The boxes represent the interquartile range, the little square
the mean, the line the median and the whiskers are the 5% and 95% quartiles. The *** symbol indicates that the two-tailed t-test p-values for
comparisons between THP1sh1/OSBPL10 and THP1/non-transfected or THP1/mock, as well as for THP1sh2/OSBPL10 and THP1/non-
transfected or THP1/mock are significant. (B) Viral load (log10 of PFU/mL), measured intracellularly and extracellularly, in the various THP1 cells
(non-transfected and transfected with mock, sh1 and sh2 plasmids) when infected by DENV2. The *** symbol indicates that the two-tailed t-test p-
values for pairwise comparisons (THP1sh1/OSBPL10 vs. THP1/non-transfected or THP1/mock, THP1sh2/OSBPL10 vs. THP1/non-transfected or
THP1/mock) are significant.
doi:10.1371/journal.ppat.1006220.g005
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and decreased LDL were observed in severe dengue. Recent metabolic and lipid profiling in
serum samples from dengue cohorts [30, 31] have reinforced these earlier findings, showing
that DENV infection causes temporary changes in metabolites involved in acute inflammatory
responses, with major perturbed metabolic pathways including fatty acid biosynthesis, fatty
acid beta-oxidation, phospholipid catabolism and steroid hormone pathway, and that progres-
sion into DSS is associated with certain metabolites (phosphatidylcholines, diacylglycerol,
phosphatidic acid, phosphatidylserine, triglycerides, and diacylglycerophosphoglycerol) that
may act in endothelial cell homeostasis and vascular barrier function. Definitely, lipids are
essential to DENV entrance and replication [32]. Flavivirus RNA synthesis and replication
occur on an extended network of modified endoplasmic reticulum (ER) membranes, and then
maturation takes place in the ER-Golgi complex [33]. These are the main cellular components
where OSBPs play a key role on cholesterol and other sterols homeostasis [34]. Our functional
assay clearly shows that knockdown of OSBPL10 expression reduces significantly DENV repli-
cation, a direct proof that the lower OSBPL10 expression profile in Africans protects this ances-
try against dengue disease. Interestingly, replication of HCV and poliovirus has been shown to
be dependent on OSBP in a PI4-kinase dependent manner, but DENV did not, possibly due to
its ligand being PI3P and not PI4P [35]. This evidence and our detected African-related signs
of association with kinases in Cuba calls for future research to be conducted in this group of
enzymes.
If the OSBPL10 gene is involved in signaling and transport of lipids, RXRA plays a role in
the second part of the cholesterol homeostasis through the LXR/RXR activation pathway, in
hepatocytes and macrophages. When cholesterol is in excess, as occurs in infection, the conse-
quent lowering of its cellular concentration is reached by oxysterol and desmosterol binding to
LXR, which forms heterodimers with RXRA in order to control the transcription activation of
many genes regulating lipid metabolism. In macrophages, RXRA also regulates the integration
of immune functions, thus defining the clinical outcome of dengue infection. Indeed, macro-
phages are key DENV target cells and also the principal source of pro-inflammatory mediators
linked to severe dengue disease. LXR/RXRA heterodimers and sumoylated LXR inhibit the
NF-kB transcription factor complex, which per se acts upon inflammatory mediators [36]. But
a negative control of LXR/RXRA dimers is exerted by IRF3, which is activated by viruses and
bacteria that entered the cell through TLR3 and TLR4 receptors, deregulating the cholesterol
control and allowing the action of NF-kB transcription factor. It has been demonstrated that
during dengue infection [24] there is down-regulation of RXRA expression in an IRF3-depen-
dent manner in the host cell, to achieve optimal IFN expression. After infection, RXRA expres-
sion resumes, suppressing the type I IFN induction. Therefore, RXRA not only maintains the
basal type I IFN and modulates the host antiviral response, but also regulates the antiviral
inflammatory response.
Remarkably, our results offer a comprehensive explanation for various independent obser-
vations made in association with dengue. RXRA forms heterodimers with VDR, previously
identified as dengue protective in Vietnamese [37]. The RXRA-VDR heterodimers negatively
control the expression of several immune function genes. Also, PLCE1, protective against DSS
in Vietnamese children [5], interacts with RXRA in the PPARA/RXRA activation pathway,
positively controlling the expression of genes again related with lipid metabolism. Perhaps fla-
vivirus resistance arose in Asians through VDR and PLCE1 selection, while OSBPL10 and
RXRA selection provided resistance in Africans, all related with central lipids and cytokines
pathways. Even the immune system genes associated with dengue illness, such as TNF-α, IL-
10, TGF-β1, FcγRIIa and CD209 [3], can also be related with the RXRA gene in several path-
ways, as their expression is controlled by dimers formed by RXRA and other nuclear factors.
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Even the signals we detected in the kinases or kinase-related genes contribute to integrate
our results in the general picture. CAMK1D is associated with chemokine, thrombin signalling
and xenobiotic metabolism (through RXRA-CAR dimers), activation of neutrophil cells and
apoptosis of erythroleukemia cells; MAPKAPK5, that responds to cellular stress and pro-
inflammatory cytokines, and the use of a specific inhibitor of this gene blocked DENV assem-
bly [38]; PIK3AP1 which may interact with OSBPL10, as it is possible that this gene is activated
by phosphatidylinositol-3-phosphate (PI3P) [39], and links Toll-like receptor signaling to
PI3K activation preventing excessive inflammatory cytokine production; SNRK possibly
expressed in the liver secretome; GNA14 activates PLC (detected in the Vietnamese dengue
GWAS) protein that generates diacylglycerol which further activates PPARA to forms hetero-
dimers with RXRA, positively controlling the expression of genes related with lipid metabo-
lism;[40] DAB-1 may play a role in PI3K binding.
The genomic and functional confirmation of the protection conferred by OSBPL10, RXRA
and related lipid metabolism against dengue illness supported in this study points out potential
therapeutic applications. The generation of synthetic ligands of LXR should be pursued [41],
given its central role in dimerization with RXRA. The possible PI3P-dependent activation of
OSBPL10 could be tested through the various PI3K inhibitors being developed in cancer treat-
ment [42]. In addition, the African protection against DHF through kinases supports pursuing
the development of kinase inhibitors as they seem to be able to block DENV assembly [38].
Materials and methods
Samples for GWAS genotyping
Havana is the capital of the country and is located in the West with 2 million inhabitants,
while Guantanamo city is located in the eastern part with over 200 thousand inhabitants. Case
samples from the two cities, collected during the 2006 dengue outbreak and classified accord-
ing to WHO [43], were included: 67 subjects from Havana with confirmed dengue infection
by DENV 4, 36 clinically classified as DF and 31 as DHF; and 70 subjects from Guantanamo
with confirmed dengue infection by DENV 3, 41 classified as DF and 29 cases as DHF. Dengue
infection was confirmed by dengue IgM detection in serum collected at day 6 of fever onset, as
well as virus isolation in Aedes albopictus cell line and RT-PCR in samples collected in the first
four days of fever [44, 45].
A screening for identifying dengue asymptomatic cases was conducted during the peak of
the 2006 outbreak. Healthy adult individuals, without any dengue clinical symptoms, relatives
or neighbours of dengue confirmed patients from three neighbourhood blocks with a high
dengue incidence, were daily visited and checked for clinical dengue symptoms over 15 days.
The ones that remained symptom free and were PCR or IgM positive were considered as
asymptomatic cases. Thirty two asymptomatic individuals from Havana and 16 from Guanta-
namo, who were unrelated to the patients included in the genotyping, were added. Forty seven
samples from healthy blood donors from Havana and 42 from Guantanamo were included as
population controls.
Havana groups are referred as HH (dengue haemorrhagic fever cases), HF (dengue fever
cases), HA (individuals with asymptomatic infection) and HC (controls). Similarly, GH, GF,
GA and GC codes were used for the Guantanamo groups.
Ethics statement
The study was conducted according to the Helsinki Declaration as a statement of ethical prin-
ciples for medical research involving human subjects [46] and was approved by the Institu-
tional Ethical Review Committee of the Institute of Tropical Medicine Pedro Kourı´ (IPK) and
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by the Ethical Committee of the Cuban National Academy of Sciences. Written informed con-
sent was obtained from all individuals.
GWAS genotyping and data quality control
Genotyping was performed for the Illumina Human Omni 25 chip and calls were obtained on
the Illumina IScan Microarray System by using the Genome Studio software. Quality control
was performed in PLINK [47], and SNPs with more than 5% missing genotypes, minor allele
frequency (MAF) below 1%, and Hardy-Weinberg equilibrium deviation p-values of less than
0.001 were filtered out. All samples were checked for missingness (threshold of 193%), outliers
in principal-component analysis (PCA), excess rate of heterozygous loci, and evidence of sec-
ond-degree relatedness or higher (identity by descent >30%; or identity by state >90%). All
studied samples passed these criteria. SNPs located in X and Y chromosomes and in mitochon-
drial DNA were removed, leading to a final account of 1,922,396 autosomal SNPs.
Global ancestry in Cuba and its influence in dengue infection outcome
Cuban samples were merged with populations from Europe, Africa, Latin America and East
Asia (Table A in S1 Text), so that the total final dataset contained 389,574 common SNPs.
Ancestry components (K, from 2 to 10) were evaluated in all Cuban groups using the program
ADMIXTURE [48], after pruning SNPs for pairwise linkage disequilibrium (r2 > 04 in
50-SNP windows), ending up with a total of 77,782 SNPs. The optimal K was estimated
through cross-validation of the logistic regression. Two-tailed Wilcoxon rank-sum tests were
applied to assess the significance between ancestry proportions in the Cuban groups.
Fine-matched population structure correction and association analysis
Global admixture information was used for fine-matched correction for population structure.
Comparison groups were organized by matching paired individuals who did not differ by
more than 2% in the African ancestry. Havana and Guantanamo individuals were included
together, but as far as possible the comparison pair was from the same city, and asymptomatic
infected individuals were considered first than controls as individuals with no dengue disease
symptoms. The groups consisted in: 54 asymptomatic/control versus DHF pairs (haemorrha-
gic comparison group—HCG); 74 asymptomatic/control versus DF pairs (fever comparison
group—FCG); 111 asymptomatic/control versus DHF and DF pairs (overall comparison
group–OCG). Single-locus allelic association analyses were carried out in PLINK [47] through
the χ2 statistics. P-values were displayed as–log10 in Manhattan plots, obtained in HaploView.
Admixture mapping
Local ancestry analysis was performed through RFMix algorithm [49]. 50 Southern European
(Italian) and 50 Yoruban samples from the 1000 Genomes database [50] represented the
parental European and African components, respectively. These samples were phased together
with the Cuban samples in SHAPEIT [51] with the fine scale HapMap phase II genetic map. A
test in chromosome 22 was performed with the Spanish sample from 1000 Genomes database
replacing the Italian to confirm that results were identical. The difference in the African pro-
portion between asymptomatic/controls and cases was calculated for every position along each
chromosome in the Cuban comparison groups (HCG, FCG and OCG), and genomic regions
significantly enriched for the African ancestry in asymptomatic/controls were considered as
being outside the range defined by the genome mean + 3SD.
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Gene expression analysis in patients with dengue illness
A group of 20 patients with suspected dengue acute illness (clinical diagnosis was made by an
experienced physician in dengue illness) were recruited at the Salvador Allende Hospital, Havana
in 2014. Dengue infection was confirmed as described above. General signs and symptoms as
well as warning signs (clinical fluid accumulation, mucosal bleeding, restlessness, severe abdomi-
nal pain, persistent vomiting as well as thrombocytopenia<100 platelets x 109/L, and 20% or
higher increase of haemo-concentration indicated by haematocrit or HTC) were recorded daily
from recruitment to discharge. Three serial peripheral mononuclear cell (PBMC) samples were
collected during hospitalization, at days 3, 7 and 30, after symptoms onset.
DNase-treated total RNA was isolated from PBMC using the RNeasy Mini kit (Qiagen, Hil-
den, Germany) and evaluated by using the Agilent 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA, USA). Expression levels of OSBPL10, RXRA and β-actin (housekeeping) genes
were determined by RT-PCR (LightCycler 2.0 instrument, Roche), using LightCycler RNA
Master SYBR Green I kit (Roche) and designed primers (Table B in S1 Text). Each sample was
duplicated and the mean Ct values were normalized to an average Ct value of the housekeeping
gene. The assay specificity was evaluated by melting curve analysis. Statistical analysis was per-
formed using the non-parametric Wilcoxon-Mann-Whitney U mean rank test for quantitative
variables.
mRNA expression in other datasets, potential functional role and positive
selection
Expression of significant genes and genotypes was checked also in public datasets: 1) 465
RNASeq performed in European and African lymphoblastoid cell lines by the 1000 Genomes
project [21], expressed in reads per kilobase of exon per million reads mapped (RPKM) and
extracted from ArrayExpress (E-GEUV-1); 2) Thai whole blood transcriptome (GDS5093)
[22] from nine healthy controls, 28 samples collected between days 2 and 9 after onset of symp-
toms (acute illness) from secondarily infected patients (18 DF and 10 DHF), and 19 samples
collected at convalescence, four weeks or later after discharge. GSEA software [52] was used
for gene set enrichment analysis of the LXR/RXR activation pathway in the Thai dengue data-
set [22] by considering three sets of genes: lipid metabolism, LXR/RXR activation and NF-kB
activation.
Haplotter database (http://haplotter.uchicago.edu/) was used to explore recent positive
selection through iHS measure (detects selective sweeps at 50–80% frequencies). By using the
selscan package [53], another measure of positive selection (XP-EHH—detects selective sweeps
above 80% frequency) was applied to the Cuban HCG.
The significant SNPs were ascertained for location in regulatory regions by using EPDNew
[54] and HaploReg [55] tools. EDPNew comprises organism-specific (we obviously used H.
sapiens) transcription start site (TSS) collections automatically assembled from carefully
selected mass sequences for genome annotation data. HaploReg annotates non-coding diver-
sity by using LD information from the 1000 Genomes Project that allows one to visualize
linked SNPs and small indels along with their predicted chromatin state, conservation across
mammals and their effect on regulatory motifs.
Cell culture, construction of plasmids and generation of OSBPL10 stable
knockdown and mock cell lines
Two OSBPL10 short hairpin RNAs (shRNA; TRCN0000147511 and TRCN0000149806 from
Sigma Aldrich, St. Louis, MO USA) were cloned in the mammalian expression vector pcDNA3.
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These shRNAs were previously reported to induce 80–90% reduction of the OSBPL10 protein
[56]. The plasmids and the control/mock plasmid were transformed into E. coli competent cells
and the positive recombinant colonies were selected and amplified. The extracted recombinant
plasmids were digested, subjected to DNA sequencing and purified by QIAprep Spin Miniprep
Kit (Qiagen, Hilden, Germany), following the recommended procedure.
THP-1 cells obtained from American Type Culture Collection (ATCC, Rockville, MD
USA) were cultured in complete grow medium RPMI1640 supplemented with 10% fetal
bovine serum (FBS), L-glutamine and 0.1 mM MEM non-essential amino acids solution
(Thermo Fisher Scientific, Waltham, MA USA) at 37˚C with 5%CO2. Transfection of the two
shRNA and mock plasmids into THP-1 cells was done by using Lipofectamine LTX Reagent
(Thermo Fisher Scientific, Waltham, MA USA) and the recombinant cells (THP1sh1/
OSBPL10, THP1sh2/OSBPL10, THP1/mock) were selected for Neomicin resistance.
Dengue virus preparation and infection of THP-1 cells
C6/36 cell lines from A. albopictus were grown to confluence, infected at a multiplicity of infec-
tion of 0.1 particle forming units (PFU) per cell with the dengue strain DENV-2 A15 Cuba
1981 and cultured in minimum essential medium (MEM) supplemented with 2% fetal calf
serum. When a cytopathic effect higher than 50% was noted, culture supernatant was clarified
by centrifugation at 10,000 rpm for 30 min at 4 ˚C. BHK21, clone 15 cell line was used for
virus titration as previously described [57]. DENV-2 A15 Cuba titer was of 2x106 PFU/ml.
Absence of lipopolysaccharide contamination in the viral preparations was confirmed by the
Limulus Amebocyte Lysate test (Bio- Whittaker Inc., Walkersville, MD USA).
THP-1 cells were infected with dengue virus at a multiplicity of infection (MOI) of 0.1. The
virus inoculum at a 70–90% confluence was incubated in serum-free medium at 37˚C for 1h.
The unadsorbed viruses were removed by washing the cells three times with plain medium.
The dengue-virus-infected and non-infected cells were replenished with fresh complete
medium and incubated for another 72 hours.
OSBPL10 mRNA expression analysis and dengue viral load
measurement by qRT-PCR
DNase-treated total RNA was isolated from all THP-1 cell variants by means of RNeasy Mini
kit (Qiagen, Hilden, Germany) and evaluated by using the Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA, USA). The cDNA was synthesized from mRNA with poly(dT)
primers and Superscript II reverse transcriptase (Life Technologies, Rockville, MD, USA) and
quantified by real-time PCR analysis using the ABI Prism 7700 sequence detection system
(Applied Biosystems, Foster City, CA, USA). Samples were analyzed in triplicates for the
expression of OSBPL10, as well as for the housekeeping gene β-actin. And each experience was
repeated three times (nine values for each condition). Specific expression was calculated in
relation to that of β-actin, by using the delta/delta Ct method as recommended by ABI.
RNA from 140 μl of OSBPL10 silenced cell line control THP-1 supernatant or cell culture
lysate was extracted, using the QIAamp viral RNA extraction kit (Qiagen, Hilden, Germany)
and amplified with TaqMan Assay. Standard curves were obtained with titrated DENV-2
supernatants serially diluted from 106 to 10 PFU/mL. The standard curve obtained by serial
dilution of titrated DENV-2 supernatants had a -3.4 slope, the amplification efficiency was of
92.2% and the detection limit was estimated at 10 PFU equivalents/mL. We performed quanti-
tative RT-PCR analyses of viral mRNA isolated from cellular extracts (intracellular) and cul-
ture supernatants (extracellular). Intracellular RNA levels indicate viral replication, whereas
extracellular viral RNA is a measure of released viral particles in the culture supernatant.
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